ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Betta Pharmaceuticals Co., Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 100 studies whose lead sponsor is Betta Pharmaceuticals Co., Ltd. or one of 3 companies grouped under it. 21 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 18, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Compare Betta Pharmaceuticals with Jiangsu HengRui Medicine and Bristol-Myers Squibb →

Pipeline: 5 programs

Each counted once: 5 with a study Betta Pharmaceuticals Co., Ltd. leads registered in the last two years.

  • Phase 2
  • Phase 3

The 3 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Betta Pharmaceuticals Co., Ltd.’s own registered studies; Betta Pharmaceuticals Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Betta Pharmaceuticals Co., Ltd.’s studies test, most open studies first — 14 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 4 more

Coming up

6 of Betta Pharmaceuticals Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. 1J’27
  4. 1F
  5. M
  6. 1A
  7. M
  8. 2J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 6 to your calendar (.ics) → With an account.

All 100 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2121%Recruiting 15 · Not yet recruiting 6
  • Under way, not recruiting55%
  • Completed2424%
  • Stopped early44%Suspended 3 · Terminated 1
  • Status unknown or other4646%Status unknown 45 · Available 1

Phase

  • Phase 150
  • Phase 238
  • Phase 312
  • Phase 48

Where

  • China91
  • United States6
  • Australia2
  • Canada1
  • Israel1
  • Italy1

Over the years

  1. 09
  2. 10
  3. 11
  4. 12
  5. 13
  6. 14
  7. 15
  8. 16
  9. 17
  10. 1318
  11. 19
  12. 20
  13. 21
  14. 22
  15. 23
  16. 24
  17. 25
  18. 726

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Betta Pharmaceuticals Co., Ltd.

  • Betta Pharmaceuticals Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    79 studies
  • AnewPharma
    Acquired — became part of Betta Pharmaceuticals Co., Ltd., Jun 15, 2017 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    14 studies →
  • Xcovery Holdings, Inc.
    Acquired — became part of Betta Pharmaceuticals Co., Ltd., May 31, 2017 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Meryx, Inc.
    Acquired — became part of Betta Pharmaceuticals Co., Ltd., 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →

Focus areas

Conditions Betta Pharmaceuticals Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 100. Browse all 100 →